A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids

David C. Currow, Katherine Clark, Sandra Louw, Belinda Fazekas, Aine Greene, Christine R. Sanderson

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids'. Together they form a unique fingerprint.

Medicine & Life Sciences